We are live on ! Find out more
CPRX

Catalyst Pharmaceutical
CPRX

Delisted

CPRX was delisted on the 14th of July, 2026.

Back to rankings

47 hedge funds and large institutions have $56.4M invested in Catalyst Pharmaceutical in 2014 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 14 increasing their positions, 3 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

367% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 3

335% more call options, than puts

Call options by funds: $87K | Put options by funds: $20K

150% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 6

138% more capital invested

Capital invested by funds: $23.7M → $56.4M (+$32.8M)

24% more funds holding

Funds holding: 38 → 47 (+9)

Holders
47
Holders Change
+9
Holders Change %
+23.68%
% of All Funds
1.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
14
Reduced
3
Closed
6
Calls
$87K
Puts
$20K
Net Calls
+$67K
Net Calls Change
+$63K

Top Buyers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
+$5.53M
2
BC
Broadfin Capital
New York
+$5.13M
3
BBA
Baker Bros. Advisors
New York
+$3.53M
4
PA
Perceptive Advisors
New York
+$3.2M
5
VAM
Visium Asset Management
New York
+$3.2M

Top Sellers

Rank Fund Capital Flow
1
Federated Hermes
Federated Hermes
Pennsylvania
-$175K
2
U
UBS
Switzerland
-$69.5K
3
CAN
Cetera Advisor Networks
California
-$54K
4
QIM
Quantitative Investment Management
Virginia
-$25K
5
Morgan Stanley
Morgan Stanley
New York
-$7K
Name Holding Trade Value Shares
Change 		Change in
Stake
Dimensional Fund Advisors
26
Dimensional Fund Advisors
Texas
$117K – – –
CPA
27
Cowen Prime Advisors
New York
$114K +$2.99K +1,400 +3%
California Public Employees Retirement System
28
California Public Employees Retirement System
California
$105K – – –
FANJ
29
Financial Architects (New Jersey)
New Jersey
$76K – – –
Group One Trading
30
Group One Trading
Illinois
$66K +$29K +13,572 +107%
Nomura Holdings
31
Nomura Holdings
Japan
$63K +$53.4K +25,000 New
Citadel Advisors
32
Citadel Advisors
Florida
$55K +$29.9K +13,979 +184%
GC
33
Guggenheim Capital
Illinois
$45K -$3.79K -1,774 -9%
RCM
34
Rotella Capital Management
Washington
$35K +$3.2K +1,500 +12%
Janney Montgomery Scott
35
Janney Montgomery Scott
Pennsylvania
$25.3K – – –
BIM
36
BlackRock Investment Management
Delaware
$25K +$21.2K +9,905 New
Creative Planning
37
Creative Planning
Kansas
$21K – – –
LTFS
38
Ladenburg Thalmann Financial Services
Florida
$14K – – –
Citigroup
39
Citigroup
New York
$9K +$7.56K +3,538 New
VIA
40
Vantage Investment Advisors
Pennsylvania
$8K – – –
S
41
SignatureFD
Georgia
$8K +$6.41K +3,000 New
AIG
42
American International Group
New York
$5.06K – – –
BRWA
43
B. Riley Wealth Advisors
Florida
$5.06K +$4.27K +2,000 New
Royal Bank of Canada
44
Royal Bank of Canada
Ontario, Canada
$5K -$120 -56 -3%
Bank of Montreal
45
Bank of Montreal
Ontario, Canada
$4K – – –
Manulife (Manufacturers Life Insurance)
46
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$2K – – –
SAM
47
Shamrock Asset Management
Texas
$1K +$427 +200 New
U
48
UBS
Switzerland
– -$69.5K -32,551 Closed
CAN
49
Cetera Advisor Networks
California
– -$54K -24,000 Closed
QIM
50
Quantitative Investment Management
Virginia
– -$25K -11,500 Closed
1
2
3

CPRX Hedge Fund Activity: Q2 2014 in Review

47 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Catalyst Pharmaceutical (CPRX) for Q2 2014, worth a combined $56.4M — up 138% from $23.7M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new CPRX positions and 6 closed out — a net gain of 9 holders — while 14 added to existing stakes and 3 trimmed.

The largest buyer was Franklin Resources, opening a new position worth an estimated $5.53M. The largest seller was Federated Hermes, cutting an estimated $175K.

  • 47 institutional investors held Catalyst Pharmaceutical (CPRX) as of Q2 2014, up from 38 in Q1 2014.
  • Funds reported $56.4M of Catalyst Pharmaceutical stock for Q2 2014, up 138% quarter-over-quarter.
  • 15 funds opened new Catalyst Pharmaceutical positions in Q2 2014 and 6 closed out, a net change of +9 holders.
  • The largest Catalyst Pharmaceutical buyer in Q2 2014 was Franklin Resources, an estimated $5.53M added.
  • The largest Catalyst Pharmaceutical seller in Q2 2014 was Federated Hermes, an estimated $175K sold.

Based on aggregated 13F filings for Q2 2014.